Sheltered neighbourhoods of dormant cells were mapped in breast tumours, while age-linked cell loss and somatic-variant accumulation were tracked in vascular smooth muscle from progeria mice.
Science··Evening
Dormant cells occupied distinct neighbourhoods in breast tumours
A team from the MRC Laboratory of Medical Sciences, Imperial College London and the UCL Genetics Institute combined single-cell and spatial sequencing from primary breast tumours. The study places a G0 state, in which cells have stopped dividing and display persister-like features, within specific neighbourhoods of tumour tissue. These cells carried a lower copy-number alteration burden, reprogrammed stress-response pathways and greater epithelial–mesenchymal plasticity. Spatial analysis located dormant cells in zones with active complement signalling, near CXCL10-bearing macrophages and myofibroblastic cancer-associated fibroblasts. Areas where division continued were instead associated with CLEC9A-bearing dendritic cells and PERK signalling. The authors infer distinct drug sensitivities for the two zone types from gene expression; this is not a treatment response measured directly in a patient. Grounded in human tumour tissue, the work therefore describes cell state not only as gene activity within a cell but as a spatial property shaped alongside neighbouring immune and connective-tissue components. The map distinguishes protected dormancy from active proliferation without establishing that one neighbouring cell type alone creates either state.[1]
Somatic variants accompanied vascular-cell loss in progeria mice
A study with Maria Eriksson as senior author followed vascular smooth-muscle cells in the aortic arch as mice carrying the murine equivalent of Hutchinson–Gilford progeria syndrome aged. Histology showed cell loss beginning at seven weeks; a 38.6 percent reduction was significant at ten weeks, and only 15.6 percent of the cells remained by fifteen weeks. The team performed Smart-seq2 single-cell RNA sequencing in progeria mice at 6, 10 and 12 weeks, with wild-type controls at 6 and 12 weeks, and called somatic variants with the SComatic algorithm. Progeria smooth-muscle cells contained 10,273 unique variants, 471 of which appeared in at least two cells from the same experimental batch. The corresponding wild-type counts were 3,958 and 76. Rising variant counts occurred alongside expression of genes tied to endoplasmic-reticulum stress, reactive oxygen species and p53. These are results from mouse tissue; the study does not show that the same numerical course occurs in human vascular disease. The authors also note that the sex distribution of the mice was not evenly spread among experimental cohorts.[2]
One study resolved place, the other advancing time, at cell scale
The studies do not investigate the same disease or one shared biological mechanism. The breast-tumour work resolves where non-dividing cells sit in human tissue and which neighbouring cells occur around them. The progeria work follows loss of vascular smooth-muscle cells across weeks in a mouse model, alongside somatic-variant burden and expression of stress-related genes. Their connection is that both expose cell states hidden beneath an average tissue signal. In the tumour, dormancy clusters in a microenvironment distinct from zones of active proliferation. In the vessel, cell numbers fall while the genomic-variant profile of remaining cells changes with age. That distinction also defines the scope of the results. The first study is not a treatment trial, and sensitivities inferred from expression are not responses measured in patients. The second does not provide a direct numerical forecast for human progeria. Together they show why “cell state” cannot be reduced to one marker: position in tissue, cellular neighbours, age, cell loss and accumulated somatic changes become connected only through different measurements made at cell-level resolution.[1], [2]
